Global Immunotherapy Drugs Market 2018 Key Players: F.Hoffmann, Merck & Co., Inc., Novartis International AG, Johnson & Johnson, Glaxosmithkline PLC, Amgen Inc., Abbvie.

Immunotherapy Drugs Market:

WiseGuyReports.com adds “Immunotherapy Drugs Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2025”reports to its database.

Executive Summary

Global Immunotherapy Drugs Market valued approximately USD 108.5 billion in 2016 is anticipated to grow with a healthy growth rate of more than 14.0% over the forecast period 2017-2025. Faster drug approval processes, rising prevalence of life style-oriented diseases, and rising adoption of targeted therapies are the primary growth drivers for global immunotherapy drugs market. However, the market growth is restricted by the high cost of immunotherapy treatment.

Global Immunotherapy market is segmented by type of drugs, therapy area and end-use. Based on therapy area the market is segmented into cancer, autoimmune & inflammatory diseases, infectious diseases, and others. Among these, currently the market is dominated by cancer segment which is anticipated to account for 33% revenue share in 2016. The cancer segment will continue to dominate over the forecast period and is also anticipated to register the highest growth over the forecast period. Increasing prevalence of cancer and rising adoption of immunotherapy for cancer treatment is driving the market growth.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type of Drugs:

Monoclonal Antibodies
Adult Vaccines
Preventive Vaccines
Therapeutic Vaccines
Checkpoint Inhibitors
Interferons Alpha & Beta
Interleukins
Other Drugs
By Therapy Area:

Cancer
Autoimmune & Inflammatory Diseases
Infectious Diseases
Other Therapy Area
By End-Use:

Hospitals
Clinics
Other End Users
Furthermore, years considered for the study are as follows:

Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025

Request Sample Report @ https://www.wiseguyreports.com/sample-request/3136526-global-immunotherapy-drugs-market-size-study-by-type

Some of the key manufacturers involved in the market F.Hoffmann, Merck & Co., Inc., Novartis International AG, Johnson & Johnson (A Parent Company of Jannssen Biotech, Inc.), Glaxosmithkline PLC, Amgen Inc., Abbvie, Amstrazeneca, Bristol-Mysers Squibb, ELI Lilly & Company Frequent cross industry partnerships are leading to market consolidation.

Target Audience of the Global Immunotherapy Drugs Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Table of Content:

Chapter 1. Global Immunotherapy Drugs Market Definition and Scope 
    1.1. Research Objective 
    1.2. Market Definition 
    1.3. Scope of The Study 
    1.4. Years Considered for The Study 
    1.5. Currency Conversion Rates 
    1.6. Report Limitation

Chapter 2. Research Methodology 
    2.1. Research Process 
      2.1.1. Data Mining 
      2.1.2. Analysis 
      2.1.3. Market Estimation 
      2.1.4. Validation 
      2.1.5. Publishing 
    2.2. Research Assumption

Chapter 3. Executive Summary 
    3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion) 
    3.2. Key Trends

Chapter 4. Global Immunotherapy Drugs Market Dynamics 
    4.1. Growth Prospects 
      4.1.1. Drivers 
      4.1.2. Restraints 
      4.1.3. Opportunities 
    4.2. Industry Analysis 
      4.2.1. Porter’s 5 Force Model 
      4.2.2. PEST Analysis 
      4.2.3. Value Chain Analysis 
    4.3. Analyst Recommendation & Conclusio

Chapter 5. Global Immunotherapy Drugs Market, by Type of Drug

Chapter 6. Global Immunotherapy Drugs Market, by Therapy Area

Chapter 7. Global Immunotherapy Drugs Market, by End-Use

Chapter 8. Global Immunotherapy Drugs Market, by Regional Analysis 

Chapter 9. Competitive Intelligence 
    9.1. Company Market Share (Subject to Data Availability) 
    9.2. Top Market Strategies 
    9.3. Company Profiles 
      9.3.1. F.Hoffmann-LA Roche AG 
          9.3.1.1. Overview 
          9.3.1.2. Financial (Subject to Data Availability) 
          9.3.1.3. Product Summary 
          9.3.1.4. Recent Developments 
      9.3.2. Merck & Co., Inc. 
      9.3.3. Novartis International AG 
      9.3.4. Johnson & Johnson (A Parent Company of Jannssen Biotech, Inc.) 
      9.3.5. Glaxosmithkline PLC 
      9.3.6. Amgen Inc. 
      9.3.7. Abbvie 
      9.3.8. Amstrazeneca 
      9.3.9. Bristol-Mysers Squibb 
      9.3.10. ELI Lilly & Company

Continuous…

For further information on this report, visit – https://www.wiseguyreports.com/reports/3136526-global-immunotherapy-drugs-market-size-study-by-type

Contact Us:

Norah Trent           

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); +44 208 133 9349 (UK)

About Us:
Wise Guy Reports Is Part Of The Wise Guy Consultants Pvt. Ltd. And Offers Premium Progressive Statistical Surveying, Market Research Reports, Analysis & Forecast Data For Industries And Governments Around The Globe. Wise Guy Reports Features An Exhaustive List Of Market Research Reports From Hundreds Of Publishers Worldwide. We Boast A Database Spanning Virtually Every Market Category And An Even More Comprehensive Collection Of Market Research Reports Under These Categories And Sub-Categories.

Addres:
WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India
Phone :+91 841 198 5042

This release was published on openPR.